[CLS] O
Selegiline O
- O
induced O
postural B
hypotension I
in O
Parkinson B
' I
s I
disease I
: O
a O
longitudinal O
study O
on O
the O
effects O
of O
drug O
withdrawal O
. O
[SEP] O

[CLS] O
CONCLUSION O
: O
This O
study O
confirms O
our O
previous O
finding O
that O
selegiline O
in O
combination O
with O
L O
- O
dopa O
is O
associated O
with O
selective O
orthostatic B
hypotension I
. O
[SEP] O

[CLS] O
In O
the O
in O
vivo O
study O
, O
the O
administration O
( O
50 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
of O
TET O
and O
FAN O
in O
mice O
showed O
the O
inhibition O
of O
thrombosis B
by O
55 O
% O
and O
35 O
% O
, O
respectively O
, O
while O
acetylsalicylic O
acid O
( O
ASA O
, O
50 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
, O
a O
positive O
control O
, O
showed O
only O
30 O
% O
inhibition O
. O
[SEP] O

[CLS] O
The O
prevalence O
rate O
for O
CIMD B
was O
12 O
% O
at O
baseline O
. O
[SEP] O

[CLS] O
Recent O
reports O
indicate O
that O
single O
agent O
therapy O
with O
vinorelbine O
( O
VNB O
) O
or O
gemcitabine O
( O
GEM O
) O
may O
obtain O
a O
response O
rate O
of O
20 O
- O
30 O
% O
in O
elderly O
patients O
, O
with O
acceptable O
toxicity B
and O
improvement O
in O
symptoms O
and O
quality O
of O
life O
. O
[SEP] O

[CLS] O
Warfarin O
- O
induced O
artery B
calcification I
is O
accelerated O
by O
growth O
and O
vitamin O
D O
. O
[SEP] O

[CLS] O
High O
doses O
of O
vitamin O
D O
are O
known O
to O
cause O
calcification B
of I
the I
artery I
media O
in O
as O
little O
as O
3 O
to O
4 O
days O
. O
[SEP] O

[CLS] O
Tamoxifen O
( O
TAM O
) O
, O
the O
antiestrogenic O
drug O
most O
widely O
prescribed O
in O
the O
chemotherapy O
of O
breast B
cancer I
, O
induces O
changes O
in O
normal O
discoid O
shape O
of O
erythrocytes O
and O
hemolytic B
anemia I
. O
[SEP] O

[CLS] O
This O
study O
was O
conducted O
to O
examine O
whether O
prolonged O
pretreatment O
with O
isoproterenol O
could O
abolish O
bromocriptine O
- O
induced O
tachycardia B
in O
conscious O
rats O
. O
[SEP] O

[CLS] O
The O
adjusted O
rate O
ratio O
of O
VTE B
for O
repeat O
users O
of O
third O
generation O
OC O
was O
0 O
. O
6 O
( O
95 O
% O
CI O
: O
0 O
. O
3 O
- O
1 O
. O
2 O
) O
relative O
to O
repeat O
users O
of O
second O
generation O
pills O
, O
whereas O
it O
was O
1 O
. O
3 O
( O
95 O
% O
CI O
: O
0 O
. O
7 O
- O
2 O
. O
4 O
) O
for O
switchers O
from O
second O
to O
third O
generation O
pills O
relative O
to O
switchers O
from O
third O
to O
second O
generation O
pills O
. O
[SEP] O

[CLS] O
Lidocaine O
reduced O
the O
area O
of O
punctate O
- O
evoked O
hyperalgesia B
significantly O
. O
[SEP] O

[CLS] O
The O
purpose O
of O
the O
present O
study O
was O
to O
examine O
the O
safety O
and O
efficacy O
of O
ketamine O
for O
sedation O
in O
the O
treatment O
of O
children O
' O
s O
fractures B
in O
the O
emergency O
department O
. O
[SEP] O

[CLS] O
As O
a O
result O
, O
switching O
to O
tacrolimus O
has O
been O
reported O
to O
be O
a O
viable O
therapeutic O
option O
in O
the O
setting O
of O
cyclosporine O
- O
induced O
TMA B
. O
[SEP] O

